Here are the top stories covered by DocWire News this week in the Hematology & Oncology section. This week, studies have linked marijuana to testicular cancer and hair dyes and chemical hair straighteners to breast cancer.
Permanent hair dyes and chemical hair straighteners increased the risk of breast cancer, particularly in black women, according to a study published in the International Journal of Cancer.
A long-term study published in JAMA Network Open found that 10 years of marijuana use is not linked to most cancers; however, low-quality evidence suggests that it could be linked to testicular germ cell tumor.
The U.S. Food and Drug Administration approved Tecentriq® (atezolizumab) in combination with Abraxane® (paclitaxel) and carboplatin for firstline treatment of adults with metastatic non-squamous non-small cell lung cancer without EGFR or ALK genomic tumor aberrations.
A simple urine test under development for prostate cancer detection can now use urine samples collected at home, according to the findings of a new study published in BioTechniques.
Diets consisting of high plant-based intake are associated with a reduced risk of prostate cancer, while diets high in dairy are associated with an increased risk of prostate cancer, according to a study published in The Journal of the American Osteopathic Association.
In case you missed it, more hem/onc headlines are featured below:
- Stricter Alcohol Policies Can Reduce the Risk of Cancer
- Consumption of Pain Medication in Patients With Cancer Has Doubled
- FDA Approves Second Drug Under New International Network Pathway for CLL/SLL
- FDA Approves Oxbryta™ for Sickle Cell Disease
- Women With Schizophrenia Less Likely to Undergo Breast Cancer Screening